{"name":"Hemera Biosciences","slug":"hemera-biosciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQZHUtRUxnM25EUHFmN2J6Y2tsek9VVE9UMUg5YmF4N0xxdG9hQjFhekV2WDlfcC1yU1dycGNjcjNoNHVOcWtnT0pVaU1jSWViQkJKeFlsMlRCSUVSOXVGSTJUaVNsWHllcGVoY0FQUkpRUWtPelV3ekxyVlVieXd3UmtKeDJXbDBmdUYwb1pxYVhpRXM0LVgxYjdyeWQ4ZFZfQjAzTHFvMlF0anNmSm12SGRn?oc=5","date":"2026-02-13","type":"trial","source":"Endpoints News","summary":"Paul Hudson couldn’t quite get Sanofi over the hump; PROTAC developer Arvinas appoints CEO - Endpoints News","headline":"Paul Hudson couldn’t quite get Sanofi over the hump; PROTAC developer Arvinas appoints CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNYmFKbWFvY3NSSG1YMjlXZnNCUV9PX2EtTkVLdjRkS1hZekFZTU1rM2EweEVlNEJjVlB6aGtwZU5rMFV2MFp4bzd5ZHVaTFFUTUZrcGdZbjBrWHl4aW5DbzF3NVJWN2lBRXVhcWg0OHF3ZjQ5QzdkRTIwX1hiZHJyTTFPc3QtQ2s2cHp3?oc=5","date":"2026-02-09","type":"pipeline","source":"The Pharma Letter","summary":"NervGen Pharma names Adam Rogers as CEO - The Pharma Letter","headline":"NervGen Pharma names Adam Rogers as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNNVBpVHl3N3BHai1ZamFmMHhib1J0SE5IVWZlbU9JdkF4cHVZQkdkUzFJdVM2Z0g4am1iX3ZNUjNKOTNVNXBtWk1zRGh2cWVPLURFd1N0WDBIYV9tUko3czFwV3FRZEtfODJCUUhmSW5kSElZWU02Tlk5QlExZFhHYUZqYm0ybWVERkdQVHB6cmlnSzA?oc=5","date":"2023-12-21","type":"pipeline","source":"BioPharma Dive","summary":"J&J bets bigger on MeiraGTx’s eye gene therapy - BioPharma Dive","headline":"J&J bets bigger on MeiraGTx’s eye gene therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOLV9lSWRmc0l3SVlYOU50aThMUEk4S2lCaHd0NUo2SjNDUU10QnM3dmJvRXVrWkR3SmE5VUhSMjA3aTBjVFdheVhWNThabTY4YUJlSWUyOGtWblpkdDdEajRBR2kxaUJGUE9JakZQMVdDb2pOeW16UVdrSUk5RlV4RTZTVGwtZmo3cFBZQWNNanJWVXRvN1E?oc=5","date":"2023-07-11","type":"pipeline","source":"Eyes On Eyecare","summary":"EyePoint Pharmaceuticals names new CEO - Eyes On Eyecare","headline":"EyePoint Pharmaceuticals names new CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxORXNSblZJSTdzUzJHMS1HNU1IRGRiSS0zeEtKZmd1b25yLUc2V085a2gwcEs3SU43MV8yVF9MZDlFb0RaTDVXRVF1QTJqdnVPa2p3RWtiUEtFTVBWWEl6LTZ4R0hkbUpqWnFWMjhUWmRMRVlBU0JrUTdKc1JrSERCRnZjYVdQZ1IzZWd4b01uaGdNTEVGX3lHMWh0WV9nMGNFTDNlaENKcDBzR2ZTSUFmZElvbER6NXhtc0E?oc=5","date":"2023-01-04","type":"pipeline","source":"Medical Marketing and Media","summary":"EyePoint Pharmaceuticals promotes Jay Duker to president and COO - Medical Marketing and Media","headline":"EyePoint Pharmaceuticals promotes Jay Duker to president and COO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNajRWbG5reUJYQ0Z1akFfMUdpNTAtYU04M3M2eUtiVFc0R0hJbGRvc08zN0hsWFpIQzlvR2xXS0xkVWJldF9sRTlyZ0lWMFRLemczY1ZvSkV1b2JlVTg1MjNiaDVRaEwxbjZmRTF3dGQxek0wQWVoU1RJUXZhdG9CSFRlUm1UaUxzYXdZek1xRTdhYXl3YkZ2UEpFU2cyR2ZPalJJRGIya1NMM3JqWFE?oc=5","date":"2020-12-02","type":"deal","source":"Fierce Biotech","summary":"Janssen buys up eye disorder gene therapy asset from Hemera Biosciences - Fierce Biotech","headline":"Janssen buys up eye disorder gene therapy asset from Hemera Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNUkhPbGVJWmNKODgta3ZfNWk1U2pJcGRQeGdKcjBTUGdPRjFvNEtHRXlHNmZmME5DOGxCZnp3dmpLQ1hndklNTjctdXRWZzhWMnNkVXJaNUlKMHVOa0VzRm16U0xWaGRwa0ZteWQxSnVnT2JsRXdXRjhITGlQenM3LWl0X3ptQUp4ckgtOUYySnZSbG9lbTlFeGJVazNtZw?oc=5","date":"2020-12-02","type":"deal","source":"BioSpace","summary":"Janssen Acquires Rights to Hemera’s Macular Degeneration Gene Therapy - BioSpace","headline":"Janssen Acquires Rights to Hemera’s Macular Degeneration Gene Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxOSWpoR2t4SkE1c0ptYzRzc3V5NlJ3MGdrR2N6R0lOS0Zod0FOazhpRGlSaVl1LW5UMktlSjBHbFNCTW5xVjEyYWVMak5lV3hFMjRmR1d1NEIzNk5DSFVscTJwbmNZU1Y2MEMtaGc5M1BHQXZsYVladnk3bWFoXzZ5ajktSEtIVDF4aFI4ZVJrYlJaXzc2bFdJYTU3MVdydl9ieU1ZVW9VQ1NqN0ZHQjAwRl93ZnZnMWsxdUN0dEZvX2dmYm5zX2hrVHNjX3hxWm1reDljNDR2WWdzeVFLc2wyU0F6bDN1UzlSaWtjNU9LUWtWeUUwTjhhanhyNVMxaVMwZkkzbi1xVkVVNlpH?oc=5","date":"2020-12-02","type":"deal","source":"PR Newswire","summary":"Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions for Late-Stage Age-Related Macular Degeneration - PR Newswire","headline":"Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions for Late-Stage Age-Related Macular Degener","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPcENiMDJOZW5XVGlvWUFOS05DSGJxbkk5aEh1YnVmNkpnTC1XbnhCRGRRODZKZEhCZmx1TU9HYW5RUEpGakpCdE9BeGE1S1FaRVlod3N6UVNvZkhMYTl4Yk1jWkVfZEgwamNud1c0akJkN2FBRk9kV3VIa1dsZ0JwX2dHWkZBZG5TSlZ6eXpjTjM?oc=5","date":"2020-12-02","type":"pipeline","source":"BioPharma Dive","summary":"J&J pushes further into eye gene therapy - BioPharma Dive","headline":"J&J pushes further into eye gene therapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}